aripiprazole has been researched along with 5-methyltetrahydrofolate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mathew, SJ | 1 |
| Das, A; Jha, S; Kumar, P; Kumar, R | 1 |
| Dar, SA; Haq, I; Wani, RA | 1 |
1 review(s) available for aripiprazole and 5-methyltetrahydrofolate
| Article | Year |
|---|---|
Treatment-resistant depression: recent developments and future directions.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Clinical Trials as Topic; Combined Modality Therapy; Deep Brain Stimulation; Depressive Disorder, Major; Drug Resistance; Electroconvulsive Therapy; Humans; Piperazines; Prognosis; Quinolones; Tetrahydrofolates; Transcranial Magnetic Stimulation; Treatment Outcome; Vagus Nerve Stimulation | 2008 |
2 other study(ies) available for aripiprazole and 5-methyltetrahydrofolate
| Article | Year |
|---|---|
Effectiveness of add-on l-methylfolate therapy in a complex psychiatric illness with MTHFR C677 T genetic polymorphism.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Fluoxetine; Humans; Lithium Compounds; Male; Methylenetetrahydrofolate Reductase (NADPH2); Obsessive-Compulsive Disorder; Polymorphism, Genetic; Tetrahydrofolates; Vitamin B Complex | 2016 |
A Comparative Study of Aripiprazole, Olanzapine, and L-Methylfolate Augmentation in Treatment Resistant Obsessive-Compulsive Disorder.
Topics: Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Humans; Obsessive-Compulsive Disorder; Olanzapine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Tetrahydrofolates; Treatment Outcome | 2021 |